| scholarly article | Q13442814 |
| P50 | author | Olivier Delattre | Q30119391 |
| Brigitte Bressac-de Paillerets | Q43376253 | ||
| P2093 | author name string | Jacques Grill | |
| Pascale Varlet | |||
| Stéphanie Puget | |||
| Julien Masliah-Planchon | |||
| Laurence Brugières | |||
| Nicolas Sevenet | |||
| Franck Bourdeaut | |||
| Rachid Abbas | |||
| Olivier Caron | |||
| Sophie Huybrechts | |||
| Dominique Valteau-Couanet | |||
| Christelle Dufour | |||
| Marine Guillaud-Bataille | |||
| Léa Guerrini-Rousseau | |||
| Fanny Fouyssac | |||
| Anne-Isabelle Bertozzi | |||
| Sophie Villebasse | |||
| Marina Dimaria | |||
| P2860 | cites work | Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome | Q24336457 |
| Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
| Dissecting the genomic complexity underlying medulloblastoma | Q24621907 | ||
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors | Q26764892 | ||
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition | Q27852966 | ||
| Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. | Q27853187 | ||
| Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system | Q28270384 | ||
| Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group | Q28277811 | ||
| Human homolog of patched, a candidate gene for the basal cell nevus syndrome | Q28281033 | ||
| Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
| Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome | Q28307305 | ||
| Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy | Q30389898 | ||
| Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature | Q30968980 | ||
| Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature | Q31043687 | ||
| Mutations in SUFU predispose to medulloblastoma | Q34133729 | ||
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
| Basal cell carcinomas in gorlin syndrome: a review of 202 patients | Q34389057 | ||
| Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples | Q35837393 | ||
| The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma | Q35993240 | ||
| Novel mutations target distinct subgroups of medulloblastoma. | Q36143877 | ||
| Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome | Q36406904 | ||
| Risk stratification of childhood medulloblastoma in the molecular era: the current consensus | Q36901551 | ||
| Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
| Family history of cancer among children with brain tumors: a critical review. | Q37050913 | ||
| Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study | Q37375947 | ||
| Targeted treatment for sonic hedgehog-dependent medulloblastoma. | Q38222028 | ||
| Germline and somatic mutations in meningiomas. | Q38413198 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| Congenital anomalies and genetic syndromes in 173 cases of medulloblastoma | Q40919074 | ||
| Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449 | Q42031842 | ||
| Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations | Q42468615 | ||
| Early diagnosis of nevoid basal cell carcinoma syndrome | Q42472273 | ||
| Hedgehog Pathway Inhibition | Q42489608 | ||
| High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. | Q42504937 | ||
| Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation | Q42510080 | ||
| Clinical and radiological features in young individuals with nevoid basal cell carcinoma syndrome | Q42511712 | ||
| Treatment of early childhood medulloblastoma by postoperative chemotherapy alone | Q46367739 | ||
| Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma | Q46959964 | ||
| Identification of a SUFU germline mutation in a family with Gorlin syndrome. | Q51932422 | ||
| Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). | Q53148301 | ||
| Family cancer history and risk of brain tumors in children: results of the SEARCH international brain tumor study. | Q53220494 | ||
| Loss of suppressor-of-fused function promotes tumorigenesis. | Q53334228 | ||
| [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant]. | Q55459584 | ||
| Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome. | Q55460687 | ||
| Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. | Q55471194 | ||
| Retrospective family study of childhood medulloblastoma. | Q55471502 | ||
| Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. | Q55476488 | ||
| Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations | Q60035710 | ||
| Vismodegib | Q84330539 | ||
| P433 | issue | 8 | |
| P921 | main subject | medulloblastoma | Q1333608 |
| P304 | page(s) | 1122-1132 | |
| P577 | publication date | 2017-11-24 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis | |
| P478 | volume | 20 |
| Q92423194 | Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines |
| Q91879154 | Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade |
| Q88737429 | Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial |
| Q91780113 | Salvage Therapy for Childhood Medulloblastoma: A Single Center Experience |
| Q89746478 | The pan-cancer landscape of prognostic germline variants in 10,582 patients |
Search more.